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ABSTRACT
Objective: With the emergency department (ED) being a high-risk site for diagnostic errors, we
sought to estimate ED diagnostic accuracy for identifying acute cerebrovascular events.
Methods: MEDLINE and Embase were searched for studies (1995–2016) reporting ED diagnos-
tic accuracy for ischemic stroke, TIA, or subarachnoid hemorrhage (SAH). Two independent re-
viewers determined inclusion. We identified 1,693 unique citations, examined 214 full articles,
and analyzed 23 studies. Studies were rated on risk of bias (QUADAS-2). Diagnostic data were
extracted. We prospectively defined clinical presentation subgroups to compare odds of
misdiagnosis.
Results: Included studies reported on 15,721 patients. Studies were at low risk of bias. Overall
sensitivity (91.3% [95% confidence interval (CI) 90.7–92.0]) and specificity (92.7% [91.7–
93.7]) for a cerebrovascular etiology was high, but there was significant variation based on
clinical presentation. Misdiagnosis was more frequent among subgroups with milder (SAH with
normal vs abnormal mental state; false-negative rate 23.8% vs 4.2%, odds ratio [OR] 7.03
[4.80–10.31]), nonspecific (dizziness vs motor findings; false-negative rate 39.4% vs 4.4%,
OR 14.22 [9.76–20.74]), or transient (TIA vs ischemic stroke; false discovery rate 59.7% vs
11.7%, OR 11.21 [6.66–18.89]) symptoms.
Conclusions: Roughly 9% of cerebrovascular events are missed at initial ED presentation. Risk of
misdiagnosis is much greater when presenting neurologic complaints are mild, nonspecific, or
transient (range 24%–60%). This difference suggests that many misdiagnoses relate to
symptom-specific factors. Future research should emphasize studying causes and designing
error-reduction strategies in symptom-specific subgroups at greatest risk of misdiagnosis.
Neurology® 2017;88:1468–1477
GLOSSARY
CI5 confidence interval; ED5 emergency department; ICH 5 intracerebral hemorrhage; NIHSS5 NIH Stroke Scale; NPV5
negative predictive value; OR 5 odds ratio; PPV 5 positive predictive value; SAH 5 subarachnoid hemorrhage.
A recent US National Academy of Medicine report highlights that medical misdiagnosis is
a major public health problem likely to affect almost everyone at least once in his or her lifetime,
sometimes with devastating consequences.1 Estimates suggest that more than 12 million Amer-
icans are misdiagnosed each year, up to half of whom may have serious preventable harms as
a result.2 Even conservative estimates that consider only hospital deaths suggest that misdiag-
nosis accounts for at least 40,000–80,000 deaths annually in the United States.3 Less is known
about the aggregate burden of misdiagnosis-related morbidity, although it is estimated that,
among hospital adverse events, 47% of diagnostic errors result in serious disability.4 A national
analysis of closed malpractice claims suggests that serious disability from diagnostic error is
probably at least as common as death.5 The worldwide burden is likely even higher.
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The emergency department (ED) is a high-
risk site for preventable errors.6 Among
adverse events in the ED deemed negligent,
most are diagnostic failures, and more than
half of closed malpractice claims in emergency
medicine are diagnosis-related.7 The majority
of these relate to inappropriate discharge, with
half of the patients released from the ED hav-
ing, in retrospect, met criteria for admission.6
The spectrum of ED diagnostic errors seen in
closed-claims malpractice cases is broad, but
some studies suggest that ED misdiagnoses
may be unevenly distributed and dispropor-
tionate for neurologic conditions. A recent
study of 242 closed ED claims found that 3
of the top 5 diagnoses were neurologic (stroke,
meningitis, spinal epidural abscess), together
accounting for 20% of diagnostic claims.7 In
this study, acute stroke claims were more than
twice as common as those for acute myocardial
infarction (13.4% vs 5.4%).7 Such results
accord with hospital records analyses indicat-
ing that deaths due to cerebrovascular events
result from diagnostic error far more fre-
quently than those due to myocardial infarc-
tion (45% vs 1%, p , 0.001).8
Stroke is a leading cause of major long-term
disability in the United States and an enor-
mous source of global disease burden.9 Among
major diagnostic errors reported by physicians,
stroke is the fourth most common.10 Closed-
claims analyses focused on neurologic condi-
tions find failure to diagnose accounts for the
majority of errors, stroke is the most common
misdiagnosis, and more than 20% occur in the
ED.11 A recent cross-sectional analysis using
linked inpatient and ED visit records across
9 US states suggested the frequency of an ini-
tial misdiagnosis in the preceding 30 days was
between 1.2% and 12.7% of all hospital stroke
admissions.12 Disproportionally higher odds
were found for patients presenting with head-
ache or dizziness, suggesting that presenting
symptoms may be an important predictor of
misdiagnosis risk.12
Nevertheless, controversy exists over the
true rate of stroke misdiagnosis in the
ED.13,14 Reported misdiagnosis rates with
acute cerebrovascular disease range from as
low as 4%15 to as high as 64%,16 depending
on the clinical population under study. While
it is clear that these rates compare unfavorably
to myocardial infarction (EDmisdiagnosis rate
;2%),17 more precise estimates would help
clarify the burden of harms from misdiagnosis
and could help identify subgroups for which
misdiagnosis-reduction interventions should
be sought.
In an effort to rigorously address this knowl-
edge gap, we conducted a systematic review of
observational studies of diagnostic accuracy for
cerebrovascular disorders in the ED. We
hypothesized that errors would be more fre-
quent in patients with milder, nonspecific, or
transient cerebrovascular manifestations.
METHODS Data sources and searches. We searched
MEDLINE (via PubMed) and Embase for articles using text
words and controlled-vocabulary terms related to misdiagnosis
or diagnosis-focused research studies (appendix e-1 at
Neurology.org). We limited our search to articles published
since 1995 and reporting on patients from 1995 or later, since
advances in neuroimaging and stroke therapy in the early 1990s
substantially altered expectations for diagnosis of patients with
possible cerebrovascular disease. Our search was updated
through February 26, 2016.
Study selection. Articles were selected by 2 independent raters
using predetermined inclusion criteria and a structured process
(appendix e-1). Our focus was studies examining the accuracy
of cerebrovascular diagnosis in the ED by ED physicians. We
sought to eliminate studies in which patients were diagnosed
largely by prehospital providers, advanced practice providers, or
consultant neurologists, although full details of the specific pro-
viders involved in ED diagnosis were not available for some stud-
ies (appendix e-2). We calculated interrater agreement on full-text
inclusion using Cohen kappa.
Data extraction and quality assessment. Quality of evidence
was assessed with respect to our primary outcome measures for
diagnostic accuracy (appendix e-3). We excluded studies with
a low diagnostic reference standard and further assessed the risk
of bias or applicability concerns for each included study using
QUADAS-2 criteria (appendix e-3). Information abstracted
from each eligible article included the type of study conducted,
the number of research participants, and the number of true-
positive, false-positive, true-negative, and false-negative
diagnoses, if available. When possible, we extracted data on the
nature of false-positive and false-negative ED diagnoses. For 10
studies, we attempted to contact the first or corresponding
author for additional study information. Seven authors
responded and 5 provided additional information.
Data synthesis and analysis. We report the accuracy of ED
diagnosis overall and by cerebrovascular condition. While several
studies reported on patients with intracerebral hemorrhage (ICH)
as well, we did not attempt to analyze those patients separately
since no numbers on false negatives and false positives could be
retrieved. We calculated sensitivity, specificity, negative predictive
value (NPV), and positive predictive value (PPV) for ED diagno-
ses for any cerebrovascular condition. Although properly consid-
ered proportions rather than rates, we use here the more common
terminology, defining the false-negative rate as 1 2 sensitivity,
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false-positive rate as 1 2 specificity, false discovery rate as 1 2
NPV, and false omission rate as 1 2 PPV (appendix e-1).
When only partial results from a particular study were reported
(e.g., no data on patients without stroke or false positives), we
excluded that study only from the relevant calculations (e.g., spec-
ificity, PPV), but not the remaining calculations (e.g., sensitivity,
NPV) (appendix e-4). Where studies included data both from an
ED population and other populations (e.g., primary care or preho-
spital), we included only results from the ED population. We pres-
ent proportions and, where appropriate, 95% confidence intervals
(CIs). Tests of heterogeneity were conducted based on the Cochran
Q test. We assessed for possible trends in diagnostic accuracy pa-
rameters over time using weighted linear regression with weights
equal to 1 over the estimated standard error of the accuracy param-
eters (equivalent to the x2 test for trend).
Three prospectively defined subgroups were analyzed sepa-
rately. Those with milder (subarachnoid hemorrhage [SAH]
without vs with altered mental status), nonspecific (dizziness vs
motor manifestations), or transient (TIA vs ischemic stroke)
symptoms were compared using odds ratios (OR).
The Cohen kappa, CI, heterogeneity statistics, trend analyses,
and OR were calculated using R v3.2.4 (Foundation for Statistical
Computing, Vienna, Austria) by a PhD biostatistician. This study
is reported in accordance with PRISMA guidelines.
RESULTS Our search identified 1,693 unique cita-
tions, of which 1,479 (87.4%) were excluded at the
abstract level. Our independent raters had good to
excellent initial agreement on inclusion of full-text
manuscripts (kappa values 0.7–0.8, appendix e-1).
After resolving initial disagreements, 23/214 (11%)
studies were considered eligible (figure 1),
representing 1.4% of the total. Four studies with
low diagnostic reference standard were among those
excluded (appendix e-1). Among the 23 studies
included in the final meta-analysis, the quality of
the diagnostic reference standard with respect to the
primary outcome measures of ED diagnostic accuracy
was judged high in 4 and moderate in 19 studies
(appendix e-3). The risk of bias and applicability
concerns using the QUADAS-2 rating system was
Figure 1 Citation search and selection flow diagram
aMEDLINE was accessed via PubMed; Embase was accessed via embase.com. bHand search of citation lists from selected
studies and investigator files identified 19 additional manuscripts for review. cAbstracts coded as yes or maybe by at least
one reviewer were included in full-text review. dAfter full-text evaluation by 2 reviewers, any differences were resolved by
discussion and adjudication by a third, independent reviewer. eDiagnostic reference standard was low in 4 studies (see
appendix e-1). fOne study was removed because of duplicate data (see appendix e-1). ED 5 emergency department.
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judged high or unclear in 0 (n 5 8), 1 (n 5 14), 2
(n5 1), or more than 2 (n5 0) of the 7 QUADAS-2
bias/applicability categories (appendix e-3).
Included studies (n 5 23) reported on 15,721
unique patients (8,975 stroke/TIA, 1,941 SAH,
697 ICH, 212 unspecified hemorrhage, 30 undeter-
mined cerebrovascular events, 3,866 cerebrovascular
mimics). In 2 studies, the breakdown between stroke
and TIA (n 5 851) was not provided.18,19 By con-
tacting authors, we were able to remove duplicate,
partially overlapping results from 2 related
reports.15,20
Aggregate sensitivity was 91.3% (95% CI 90.7%–
92.0%) (false-negative rate 8.7%) and specificity was
92.7% (91.7%–93.7%) (false-positive rate 7.3%)
(table 1). For sensitivity (n 5 13 studies), the I2
statistic for heterogeneity was 98.6%, indicating high
variation across studies due to heterogeneity (p ,
0.001, Cochran Q test). For specificity (n 5 3 stud-
ies), the I2 statistic for heterogeneity was 99.8%, indi-
cating high variation across studies due to
heterogeneity (p , 0.001). Forest plots are provided
in figure 2 for sensitivity, specificity, NPV, and PPV.
Analysis for time effects identified no significant trend
in diagnostic accuracy over the defined study period.
Heterogeneity across studies appeared to correlate
with differences in included stroke subpopulations.
Table 2 shows subgroup analyses for patients
with ischemic stroke, TIA, and SAH. Diagnostic
accuracy parameters for individual studies are shown
in appendix e-4.
Selected studies permitted comparison of diagnos-
tic accuracy for those with mild, nonspecific, and
transient symptoms (table 3). These prospectively
defined subgroups were at significantly higher risk
of a missed diagnosis (range 24%–60%) than their
counterparts with more severe, specific, or persistent
deficits. The aggregate false-negative rate was 29.4%
(24.8%–33.9%) for subtle vs 4.3% (3.8%–4.9%) for
obvious presentations, OR 9.16 (7.09–11.84). The
aggregate false discovery rate was 58.9% (52.5%–
65.2%) for subtle vs 26.1% (22.3%–29.9%) for
obvious presentations, OR 4.06 (2.92–5.63). We
could not calculate a false-positive rate because these
studies did not report true negatives.
Initial ED diagnoses in missed cases (false nega-
tives) were available for 352 of 647 patients.
Migraine and nonmigrainous headaches (26.1%)
and vertigo/dizziness (14.5%) were the most fre-
quent initial diagnostic categories (appendix e-5).
Among these, 81.5% (n 5 75/92) of cases initially
misdiagnosed as headache received a final diagnosis
of SAH, while 100% (n 5 51/51) of cases initially
diagnosed as vertigo/dizziness turned out to be
ischemic strokes or TIAs. Correct final diagnoses
in stroke mimics initially misdiagnosed as stroke
(false positives) were available for 966 of 1,208 pa-
tients. Seizures (16.7%), vertigo/dizziness (9.4%),
and migraine (8.1%) were the most frequent final
diagnoses (appendix e-5).
Misdiagnoses were also noted to vary in nonpro-
spectively defined subgroups. For ischemic stroke,
increased risk of misdiagnosis was associated with
demographic factors (younger age,25,38 lack of history
of vascular risk factors33), provider cognitive factors
(imprecise history taking),33 and systems factors (ED
assessment in nonteaching [community] hospitals38
or in hospitals without a neurology residency24). Four
studies stratified misdiagnoses in ischemic stroke by
age, demonstrating higher rates of missed strokes in
patients younger than 35 years (relative to those aged
35–49 years)25 and younger age among those found
to have stroke/TIA mimics (mean/median age 47–65
years vs 65–73 years27,29,38). Two studies found that
posterior circulation strokes were missed more often
than anterior circulation strokes (37% vs 16%, p ,
0.00128; OR 3.78 [1.87–7.63]27). Two other studies
identified a tendency for lower NIH Stroke Scale
(NIHSS) scores in missed strokes (mean 2.8 vs 6.4,
p 5 0.07628; median 3 vs 6, p 5 0.2127). For SAH,
Table 1 Overall emergency department (ED) diagnostic accuracy for acute cerebrovascular events
Diagnostic parameter Formula Studies, n ED patient sample, n Value, % (95% CI)
Sensitivity TP/(TP 1 FN) 1215,16,18–28 10,536 91.3 (90.7–92.0)
False-negative rate 1 2 Sensitivity 1215,16,18–28 10,536 8.7 (8.0–9.3)
Specificity TN/(TN 1 FP) 318,20,26 3,663 92.7 (91.7–93.7)
False-positive rate 1 2 Specificity 318,20,26 3,663 7.3 (6.3–8.3)
NPV TN/(TN 1 FN) 318,20,26 3,663 92.6 (91.6–93.5)
False discovery rate 1 2 NPV 318,20,26 3,663 7.4 (6.5–8.4)
PPV TP/(TP 1 FP) 1415,18,20,26,29–38 10,907 84.7 (84.1–85.3)
False omission rate 1 2 PPV 1415,18,20,26,29–38 10,907 15.3 (14.7–15.9)
Abbreviations: CI5 confidence interval; FN5 false negatives; FP5 false positives; NPV5 negative predictive value; PPV5
positive predictive value; TN 5 true negatives; TP 5 true positives.
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increased risk of misdiagnosis was associated with
demographic factors (,12 years of education),22 dis-
ease factors (small volume of SAH),22 and systems
factors (ED assessment in nonteaching [community]
hospitals increased risk 2.1-fold [1.02–4.44]).21 The
greater risk of missed SAH in nonteaching hospitals
could not be explained by decreased availability of CT
imaging.21
DISCUSSION Our study suggests that ED diagnosis
of cerebrovascular events is fairly accurate but misdi-
agnosis still occurs at a nontrivial rate (false-negative
Table 2 Emergency department (ED) diagnostic accuracy by type of cerebrovascular event
Cerebrovascular event type
ED patient
sample, n
Misdiagnoses
(FN 1 FP), n (%)
Sensitivity, %
(95% CI)
NPV, %
(95% CI)
Specificity, %
(95% CI)
PPV, %
(95% CI)
Ischemic stroke or TIA, aggregate 13,918 1,728 (12.4) 90.8 (90.1–91.6) 92.6 (91.6–93.5) 92.7 (91.7–93.7) 84.7 (83.9–85.5)
Stroke and TIA, admixeda 5,759b 708 (12.3) 88.2 (87.0–89.4) 94.4 (93.5–95.2) 94.1 (93.2–95.0) 84.9 (83.5–86.3)
Stroke >> TIAa 7,599c 787 (10.4) 93.2 (92.3–94.1) 52.8d 59.1d 87.7 (86.7–88.6)
TIA only32,36,37 560 233 (41.6) — — — 58.4 (54.3–62.5)
SAH only21–23 1,803 127 (7.0) 93.0 (91.8–94.1) — — —
Total 15,721 1,855 (11.8) 91.3 (90.7–92.0) 92.6 (91.6–93.5) 92.7 (91.7–93.7) 84.7 (84.1–85.3)
Abbreviations: CI 5 confidence interval; FN 5 false negatives; FP 5 false positives; ICH 5 intracerebral hemorrhage; NPV 5 negative predictive value; PPV
5 positive predictive value; SAH 5 subarachnoid hemorrhage.
a Studies were assigned to the stroke .. TIA group if stroke accounted for more than 80% of reported cases, otherwise to the stroke and TIA admixed
group. Studies were also assigned to the admixed group if no separate numbers for stroke and TIA were provided in the study report.
b This includes 167 patients with ICH and 68 with SAH who could not be disaggregated from the stroke and TIA numbers, reflecting 4.1% of all patients in
this group.
c This includes 689 patients with ICH and 123 with SAH who could not be disaggregated from the stroke and TIA numbers, reflecting 10.7% of all patients
in this group.
dData from a single study only; therefore no CIs reported.26
Figure 2 Emergency department (ED) diagnostic accuracy for acute cerebrovascular events by study:
Sensitivity, specificity, positive predictive values (PPV), and negative predictive values (NPV)
Forest plots show sensitivity, specificity, PPV, and NPV (mean [95% confidence interval]) in ED diagnosis of cerebrovascu-
lar events. Results are shown by study and pooled. Note significant heterogeneity across studies, discussed in the text.
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rate5 8.7%; false-positive rate5 7.3%), even in the
era of modern neuroimaging. Given that there are
roughly 1.2 million cerebrovascular events each year
(800,000 strokes and 200,000–500,000 TIAs),39 the
estimated false-negative rate likely corresponds to
more than 100,000 missed events each year in the
United States alone. Given the greater risks of harm
associated with false-negative diagnoses,40 ED
thresholds for considering a stroke diagnosis may be
too high. Importantly, our prospectively defined
subgroup analyses found that patients with less
obvious manifestations of cerebrovascular disease
were far more likely to be missed (29.4% vs 4.3%,
false-negative rate) and also overcalled (58.9% vs
26.1%, false discovery rate), indicating that these
subgroups should be the principal targets for
interventions seeking to reduce cerebrovascular
disease misdiagnosis.
Our results point to isolated dizziness and head-
ache symptoms as the most common clinical contexts
for missed cerebrovascular disease. For dizziness,
where the primary misdiagnosis in stroke patients is
vestibular neuritis or other peripheral-vestibular dis-
order,41 misdiagnosis is understandably more fre-
quent without limb weakness.42 For headache,
where the primary misdiagnosis in patients with
SAH is migraine/other benign headache,21 misdiag-
nosis is understandably more frequent without altered
mental state.23 These findings reinforce large-scale
studies using administrative data that show strong
temporal associations between ED treat-and-release
visits for benign (presumably isolated) dizziness or
headaches and subsequent inpatient hospital stroke
admissions.12,43 Two related associations are the
increased risk of missed posterior circulation stroke
(typically presenting with dizziness, headache, and
other nonclassical stroke symptoms44) and stroke with
low NIHSS (known to be associated with posterior
circulation strokes45). When atypical symptoms are
also transient, diagnostic accuracy may decline pre-
cipitously. Posterior circulation TIAs most com-
monly present with transient, isolated vertigo44; in
such cases, the missed-stroke rate at first medical con-
tact may rise as high as 90%.44
There are probably multiple reasons for high cere-
brovascular disease misdiagnosis rates among those
with milder, nonspecific, or transient clinical manifes-
tations. The simplest is the low signal-to-noise ratio,
since dangerous causes are far outnumbered by
benign ones in patients presenting common symp-
toms (e.g., headaches or dizziness) absent obvious
red flags for cerebrovascular disease. Another is that
those with transient neurologic symptoms usually
appear well at the time of assessment without residual
neurologic symptoms or signs, rendering bedside
examination and confirmatory tests such as neuroi-
maging far less effective in diagnosis. There is also evi-
dence that cognitive errors (including knowledge
gaps, misconceptions, flawed mental models, and bias
among providers) play an important role.42 For exam-
ple, the absence of cognitive, speech, or motor find-
ings appears to place stroke patients at considerably
higher risk of being missed,19 presumably because
such clinical findings are mistakenly considered sine
qua non accompaniments for stroke.42 Frequent use
of an outdated paradigm for diagnosing dizziness is
another contributor.42,46 False reassurance by negative
CT brain imaging is also a factor.42
Demographic risk factors for cerebrovascular mis-
diagnosis include having less than 12 years of educa-
tion,22 being a woman, being a minority, and, in
particular, being younger (age ,45 years).12 Sex
and race increase stroke misdiagnosis risk by 20%–
30%12; proposed explanations for these disparities in
care quality include more atypical clinical manifesta-
tions among women and minorities as well as implicit
Table 3 Variation in likelihood of misdiagnosis based on subtle vs obvious clinical phenotype
Cerebrovascular
condition Clinical comparison
Diagnostic
parameter Subtle, n
Subtle, %
(95% CI) Obvious, n
Obvious, %
(95% CI)
OR
(95% CI)
SAH Milder: without vs with
mental status changea
False-negative
rate
24821–23 23.8 (18.5–29.1) 1,55321–23 4.2 (3.2–5.3) 7.03 (4.80–10.31)
Ischemic stroke Nonspecific: dizziness
vs motor symptoms
False-negative
rate
13716,19,20,28 39.4 (29.6–49.2) 3,70415,16,19,27,28 4.4 (3.7–5.0) 14.22 (9.76–20.74)
TIA Nonspecific: dizziness
vs motor symptoms
False discovery
rateb
5536,37 56.4 (43.3–69.5) 30436,37 35.9 (30.5–41.2) 2.31 (1.29–4.14)
Ischemic stroke Transient: TIA vs
completed strokec
False discovery
rateb
17620,32,36 59.7 (52.4–66.9) 20620,33 11.7 (7.3–16.0) 11.21 (6.66–18.89)
Abbreviations: CI 5 confidence interval; OR 5 odds ratio; SAH 5 subarachnoid hemorrhage.
a In one study, mental status was not explicitly reported.21 We therefore used triage acuity as approximation. Cases triaged as less urgent or nonurgent
were assumed to have normal mental status and were therefore considered Hunt-Hess Grade I or II, while cases triaged as resuscitation, emergent, or
urgent were assumed to have abnormal mental status and were therefore rated as Hunt-Hess Grade III-V.
bWe could not calculate the false-positive rate because these studies did not report true negatives. We substituted false discovery rate as a surrogate.
c In Ferro et al.,32 10 cases with initial ED diagnosis of TIA were later confirmed to be ischemic stroke. We counted these as correct ED physician diagnoses,
including them as true positive cases alongside the 4 confirmed TIA cases.
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bias in providers. Age is particularly noteworthy as
youth increases stroke misdiagnosis risk nearly 7-
fold (patients 18–45 years vs those.75 years).12 This
is not surprising since, among younger patients, the
prevalence of strokes is low and the prevalence of
stroke mimics high, again reducing the signal-to-
noise ratio. Although fewer in total number, stroke
misdiagnoses in younger patients can be devastating40
and likely have profound societal consequences given
the high economic costs of death or disability, includ-
ing long-term care.47
Systems risk factors for cerebrovascular disease
misdiagnosis are less well-studied, but include evalu-
ation at nonacademic, community hospital EDs or
those without a neurology residency. Variability
across hospitals was shown to be substantial in the
2 studies that assessed it, with hospital-specific rates
of misdiagnosis ranging widely from 0% to 100%
for SAH21 and 0.8% to 6.4% for stroke/TIA.38 Our
systematic review deliberately focused on the accuracy
of initial ED diagnoses rendered by ED physicians.
Some studies suggest patient evaluation by board-
certified neurologists or even neurology residents
may be linked to a lower risk of stroke misdiagno-
sis.24,38 However, neurologists generally assess pa-
tients after evaluation is already in progress and
usually have access to additional data. Furthermore,
misdiagnoses still occur even when specialists perform
the initial ED assessment. This is particularly true for
patients with nonclassical symptoms such as dizzi-
ness, with neurologic accuracy reported as low as
74.2% (sensitivity 86.5%; specificity 65.3%).48 It is
also possible that specialists may trade greater sensi-
tivity for lower specificity, given that patients who
receive IV thrombolysis (who typically have obvious,
classical stroke manifestations), generally under the
direction of a specialist, are found to have stroke
mimics at rates of 2.8%–14.0%.49–51
The real-world effects of these errors on patient
outcomes is incompletely understood, since most
studies of diagnostic accuracy use cross-sectional de-
signs without longitudinal follow-up. Nevertheless,
available studies suggest the effects of misdiagnosis
could be profound. One reviewed study found that
a third of missed strokes would have been eligible
for recombinant tissue plasminogen activator treat-
ment28 and another found 4-fold higher mortality
(OR 4.4 [1.8–10.5]) after missed stroke.27 It has been
estimated that, of the roughly 45,000–75,000 missed
strokes in patients presenting with dizziness to US
EDs annually, perhaps 15,000–25,000 have prevent-
able major stroke after missed opportunities to
promptly treat minor stroke/TIA.43 Although crude
SAH mortality in a population-based sample was
lower among those misdiagnosed (presumably
because of a milder illness spectrum),21 when adjusted
for initial severity, the odds of death or severe disabil-
ity at 1 year in patients with mild SAH who were
initially misdiagnosed vs correctly diagnosed at first
contact was 3-fold higher (OR 3.1 [1.2–7.7]).22 This
indicates that cerebrovascular disease misdiagnosis,
even in cases with milder initial presentations, is
probably associated with nontrivial, preventable
harms to patients.
Whether these cerebrovascular disease error rates
are acceptable or unacceptable is a matter for public
debate, although the absolute misdiagnosis rate is
probably high enough to envision systems-oriented
solutions that could produce a measurable reduction
in misdiagnosis or misdiagnosis-related harms at rea-
sonable cost. Routine access to ED neurologists, sug-
gested by some,13 is probably impractical, although
telemedicine could facilitate greater access.52 Indis-
criminate use of expensive neuroimaging (CT/MRI)
is neither accurate enough53 nor likely to be cost-
effective.54,55 For common neurologic symptoms such
as dizziness or headaches, cannot-miss-diagnosis
reminder checklists and symptom-oriented diagnostic
decision support have been proposed as possible sol-
utions3 and deserve further exploration. Although not
all patients can be definitively diagnosed by bedside
assessment alone, risk stratification on the basis of
particular symptom details (e.g., abruptness of head-
ache onset, onset during exertion)56,57 or subtle signs
(e.g., eye movement findings in those with acute diz-
ziness)58 into high- or low-risk groups is often possi-
ble, even when less obvious neurologic manifestations
are lacking.41 Such approaches offer the potential to
provide cost-effective reductions in misdiagnosis-
related harms,54 potentially facilitated by the use of
novel technologies. It is likely, however, that
improved diagnosis will also require some degree of
culture change,59 with enhanced communication and
teamwork among ED physicians, neurologists, and
other providers.59,60
Our study has limitations. It is possible that we
missed evidence related to cerebrovascular misdiagno-
ses. We reviewed only the English language literature
and ICH was not an explicit part of our search. Pub-
lication bias could have favored reports indicating
a higher (or lower) misdiagnosis rate. Some studies
were of modest quality (definitions, standards, report-
ing), and diagnostic uncertainty expressed by ED
physicians (e.g., “suspected TIA” or “stroke vs sei-
zure”) was inconsistently handled across studies. In
some studies, neurology residents contributed to the
initial ED diagnosis along with emergency physi-
cians,29,34–36,38 or neurologists were consulted by tele-
phone.28,38 Because most studies did not report on
how quickly diagnostic errors were recognized or
the exact timing of these errors relative to imaging
decisions, it is difficult to know if some errors simply
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reflected an initial, rough diagnostic assessment or
a reasoned decision in an uncertain case to consult
neurology, rather than directly ordering an MRI.
These methodologic issues could have led to either
overestimation or underestimation of misdiagnosis
rates. We had large aggregate sample sizes, but a rela-
tively small number of studies for some of our meas-
ures; the narrowness of our CIs may therefore
overstate the precision of our results. Source studies
did not systematically explore risk factors and causes
for misdiagnosis (including variation at the individual
provider level), limiting inferences about ideal
solutions.
Our systematic review indicates that cerebrovascu-
lar disorders are misdiagnosed in the ED at nontrivial
rates. There may be more than 100,000 missed cere-
brovascular events each year in the United States
alone. These misdiagnoses likely confer important
risks of harm to patients from missed treatment
opportunities and represent yet another unmeasured
aspect of health disparities for women
and minorities. There appears to be substantial varia-
tion in misdiagnosis rates based on clinical presenta-
tion, with milder, nonspecific, and transient
symptoms carrying the greatest risk of misdiagnosis.
Patients are most likely to receive an accurate cerebro-
vascular diagnosis in the presence of persistent cogni-
tive or motor deficits and least likely to be accurately
diagnosed when presenting with transient symptoms
or isolated dizziness, vertigo, or headaches, especially
if they are young. The most frequently identified
stroke mimics mistakenly called strokes (7.3% false
positives) were seizures, migraines, and inner ear dis-
orders, which should be considered in the differential
diagnosis. Future research to reduce cerebrovascular
disease misdiagnosis or mitigate harms from diagnos-
tic error should begin by focusing on these high-risk
for misdiagnosis subgroups. These studies should
define the effects of misdiagnosis on clinical outcomes
and identify practical systems-oriented interventions
to reduce them.
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